🔎 Trials Near Me

Home › Non-Hodgkin Lymphoma › Colorado › Denver

Pag-aaral pangklinika para sa Non-Hodgkin Lymphoma sa Denver, CO

14 pag-aaral para sa Non-Hodgkin Lymphoma ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Denver (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

Nagre-recruitPhase 2
  • Colorado Blood Cancer Institute ( Site 2726), Denver
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT04728893

A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)

Nagre-recruitPhase 1/2
  • Colorado Blood Cancer Institute ( Site 7000), Denver
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07519772

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

Nagre-recruitPhase 1
  • Colorado Blood Cancer Institute, Denver
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07101328

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

Nagre-recruitPhase 1
  • Colorado Blood Cancer Institute, Denver
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07226843

Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma

Nagre-recruitPhase 1
  • Colorado Blood Cancer Institute (Sarah Cannon), Denver
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT05798897

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

Nagre-recruitPhase 1/2
  • Colorado Blood Cancer Institute, Denver
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT05826535

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Nagre-recruitPhase 1/2
  • Colorado Blood Cancer Institute, Denver
Edad 13 hanggang 90 · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT06533579

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

Nagre-recruitPhase 3
  • Colorado Blood Cancer Institute, Denver
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT07188558

DALY II USA/ MB-CART2019.1 for DLBCL

Nagre-recruitPhase 2
  • Colorado Blood Cancer Institute, Denver
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 13, 2026 · NCT04792489

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Nagre-recruitObservasyonal na pag-aaral
  • Presbyterian St. Luke's/Colorado Blood Cancer Institute, Denver
Lahat ng edad · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT01351545

SynKIR-310 for Relapsed/Refractory B-NHL

Nagre-recruitPhase 1
  • Colorado Blood Cancer Institute, part of Sarah Cannon Cancer Institute, Denver
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 14, 2026 · NCT06544265

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Nagre-recruitObservasyonal na pag-aaral
  • Kaiser Permanente-Franklin, Denver
  • Colorado Blood Cancer Institute, Denver
  • Rocky Mountain Cancer Centers-Midtown, Denver
  • at 1 pa
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 17, 2026 · NCT06418204

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral
  • Massive Bio SYNERGY-AI site, Denver
Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

Nagre-recruitPhase 1
  • Colorado Blood Cancer Institute, Denver
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2025 · NCT05780034

Pag-aaral para sa Non-Hodgkin Lymphoma sa ibang lungsod

Iba pang pag-aaral sa Denver

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.